MK-0954E

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-0954E, covering 2017-01-26 to 2017-01-27. Get the full timeline:

Most recent: Clinical Trial Update: MK-0954E Study in Participants With Hypertension (MK-0954E-357) [Phase 3]